Jusmiral Holdings to sell up to 5.1% stake in Cohance Lifesciences via block deal: Sources

As of the market close on 17 September 2025, Cohance shares traded at around ₹967.70 per share, down 2.2%. This price is well off its 52-week high of ₹1,359, and has declined from earlier in the year — the stock is down about 9.7% year-to-date.

Leave a Reply

Your email address will not be published. Required fields are marked *